Friday, August 06, 2021 8:54:19 AM
4:26 pm ET August 5, 2021 (Benzinga) Print
BeyondSpring Inc (NASDAQ: BYSI) recently announced positive topline data from its DUBLIN-3 registrational trial in plinabulin in combination with docetaxel for the treatment of second and third line non-small cell lung cancer.
The study showed survival benefits and side effect reduction, BeyondSpring CEO Lan Huang said Thursday on Benzinga's Stock Market Livestream.
BeyondSpring is focused on developing transformative cancer medicines for patients, Huang said.
BeyondSpring has plans to discuss the company's positive trial data with the FDA later this year, she said.
There are 1.9 million patients who develop lung cancer globally each year, Huang said, adding the market for BeyondSpring is "huge."
The stock surged nearly 150% higher following the announcement this week. The BeyondSpring CEO told Benzinga the company doesn't have any plans to initiate a share offering at this time.
Huang told Benzinga BeyondSpring has $91 million on its balance sheet, which will take the company into July of 2022.
She attributes the dramatic move in the stock price to the better-than-expected trial results.
Along with the ongoing plinabulin trials, the company has three other preclinical drug trials in the pipeline, Huang said.
BeyondSpring is always thinking about potential partnerships that could help accelerate the development of the company's transformative cancer medicines, the CEO said.
BeyondSpring's current FDA submission received FDA priority review with a PDUFA date of Nov. 30.
The November deadline "is definitely a very important day," Huang told Benzinga.
BYSI Price Action: BeyondSpring shares pulled back 18.36% in Thursday's session, closing at $21.70.
See the full interview here:
BYSI Price Action: BeyondSpring has traded as high as $30 and as low as $8.90over a 52-week period.
At last check Thursday, the stock was down 15.90% at $22.29.
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
New York Yankees and Duke Basketball
Recent BYSI News
- Form F-3 - Registration statement by foreign private issuers • Edgar (US Regulatory) • 06/12/2024 09:11:48 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/12/2024 08:30:29 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/12/2024 12:30:36 PM
- BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics • GlobeNewswire Inc. • 05/16/2024 12:00:00 PM
- BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics • GlobeNewswire Inc. • 05/03/2024 11:00:00 AM
- BeyondSpring Provides Business Update and Reports Year End 2023 Financial Results • GlobeNewswire Inc. • 04/29/2024 09:30:00 PM
- BeyondSpring Files 2023 Annual Report on Form 20-F • GlobeNewswire Inc. • 04/29/2024 09:30:00 PM
- BeyondSpring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in a Phase 2 Investigator-initiated Study of First-Line Extensive-Stage Small-Cell Lung Cancer • GlobeNewswire Inc. • 03/25/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/26/2024 01:01:19 PM
- BeyondSpring Regains Compliance with Nasdaq Minimum Bid Price and Periodic Filing Requirements • GlobeNewswire Inc. • 02/26/2024 01:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:30:59 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/02/2024 09:30:32 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/16/2024 09:30:13 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/10/2024 08:00:38 PM
- BeyondSpring Receives Nasdaq Delinquency Notice Regarding Late Filing of Its Form 6-K • GlobeNewswire Inc. • 01/10/2024 08:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/18/2023 09:31:23 PM
- BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements • GlobeNewswire Inc. • 12/18/2023 09:30:00 PM
- BeyondSpring Presents Poster Highlighting Preclinical and Clinical POC Immunomodulating Activity of Plinabulin Inducing Dendritic Cell Maturation and Re-sensitization in Immunotherapy Refractory Tumors when Combined with Radiation and PD-1/PD-L1 Inhibitors • GlobeNewswire Inc. • 11/07/2023 12:00:00 PM
- BeyondSpring and Professor K. Eisenmann of the University of Toledo College of Medicine Present Poster Highlighting Plinabulin’s Anti-cancer Efficacy in Primary and Recurrent Glioblastoma Patient Derived Invasive Neurosphere Models • GlobeNewswire Inc. • 10/31/2023 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/30/2023 12:05:19 PM
- BeyondSpring Regains Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 10/30/2023 12:00:00 PM
- SEED Therapeutics Discloses Novel Molecular Glue IND Candidate for Cancer at “Targeted Protein Degradation Think Tank” Symposium • GlobeNewswire Inc. • 10/26/2023 12:30:00 PM
- SEED Therapeutics, a BeyondSpring Subsidiary, Appoints Mr. Ko-Yung Tung to the Board of Directors • GlobeNewswire Inc. • 10/23/2023 11:45:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/04/2023 08:00:38 PM
- BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements • GlobeNewswire Inc. • 10/04/2023 07:55:00 PM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM